Showing results (171-180 of 877) with videos related to
Sort By:
Pageof 88
Cancer Investigation|January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatmentG L Wampler, W H Carter, E D CampbellInjury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|September 1, 1995
General practitioners' attitudes to child injury prevention in the UK: a national postal questionnaireY H Carter, P S Morgan, R J LancashireNature Genetics|November 14, 1997
Communal discourse as a supplement to informed consent for genetic researchM W Foster, A J Eisenbraun, T H CarterControlled Clinical Trials|June 1, 1981
Analysis of survival data with nonproportional hazard functionsD M Stablein, W H Carter, J W NovakFundamental and Applied Toxicology : Official Journal of the Society of Toxicology|December 1, 1985
Application of response surface methods for evaluating the interactions of soman, atropine, and pralidioxime chlorideW H Carter, D E Jones, R A CarchmanCancer Treatment Reports|March 1, 1978
Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraintsG L Wampler, W H Carter, V R WilliamsArchives of Emergency Medicine|December 1, 1992
Causes of fatal childhood accidents in North Staffordshire, 1980-1989M J Bannon, Y H Carter, K T MasonFamily Practice|February 5, 2004
Developing research management and governance capacity in primary care organizations: transferable learning from a qualitative evaluation of UK pilot sitesSara Shaw, Fraser Macfarlane, Colin Greaves, et al.Annals of Neurology|June 3, 2004
The dopamine transporter: importance in Parkinson's diseaseJohn G Nutt, Julie H Carter, Gary J SextonCancer Immunology, Immunotherapy : CII|January 1, 1982
Immunotherapy for remission maintenance in acute myeloblastic leukemiaM A Baker, R N Taub, W H CarterPageof 88